The Global Homozygous Familial Hypercholesterolemia Market is estimated to be valued at US$ 586.6 Mn in 2025 and is expected to exhibit a CAGR of 8.4 % over the forecast period 2025 to 2032. https://timessquarereporter.com/news/homozygous-familial-hypercholesterolemia-market-to-surge-on-novel-therapeutics